GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amin Pharmaceutical Co (XTEH:AMIN1) » Definitions » Current Deferred Revenue

Amin Pharmaceutical Co (XTEH:AMIN1) Current Deferred Revenue : IRR0.00 Mil (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Amin Pharmaceutical Co Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Amin Pharmaceutical Co's current deferred revenue for the quarter that ended in . 20 was IRR0.00 Mil.

Amin Pharmaceutical Co Current Deferred Revenue Historical Data

The historical data trend for Amin Pharmaceutical Co's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amin Pharmaceutical Co Current Deferred Revenue Chart

Amin Pharmaceutical Co Annual Data
Trend
Current Deferred Revenue

Amin Pharmaceutical Co Semi-Annual Data
Current Deferred Revenue

Amin Pharmaceutical Co Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Amin Pharmaceutical Co's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Amin Pharmaceutical Co (XTEH:AMIN1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Abolfazl Street, Bostan Heftam West Alley, No. 4, 2nd floor, Marzdaran, Tehran, IRN
Amin Pharmaceutical Co is engaged in the manufacturing of pharmaceutical products, chemical drugs, herbal medicines, and nutritional supplements. It offers antimicrobials, cardiovascular, antidiabetic, cerebellar, gastrointestinal, antibiotic and antifungal, and hypoglycemic agents among others. It develops drugs in the form of plain and overlaid tablets, hard, and soft capsules, oral drops, syrups, and suspensions. Products offered by the company include Acarbose, Sitagliptin, Fampridine, Ofloxacin, Amiodarone, Ibuprofen, Zolpidem, Bilberry, Thyme, and others. Amin also exports its products to Afghanistan, Kazakhstan, Uzbekistan, and Iraq.

Amin Pharmaceutical Co (XTEH:AMIN1) Headlines

No Headlines